{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:25:52Z","timestamp":1790457952010,"version":"4.1.0"},"reference-count":44,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2003,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n            KatG catalyzes the activation of the antitubercular agent isoniazid to yield an inhibitor targeting enoyl reductase (InhA). However, no firm biochemical link between many KatG variants and isoniazid resistance has been established. In the present study, six distinct KatG variants identified in clinical\n            <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n            isolates resistant to isoniazid were generated by site-directed mutagenesis, and the recombinant mutant proteins (KatG\n            <jats:sup>A110V<\/jats:sup>\n            , KatG\n            <jats:sup>A139P<\/jats:sup>\n            , KatG\n            <jats:sup>S315N<\/jats:sup>\n            , KatG\n            <jats:sup>L619P<\/jats:sup>\n            , KatG\n            <jats:sup>L634F<\/jats:sup>\n            , and KatG\n            <jats:sup>D735A<\/jats:sup>\n            ) were purified and characterized with respect to their catalase-peroxidase activities (in terms of\n            <jats:italic>k<\/jats:italic>\n            <jats:sub>cat<\/jats:sub>\n            \/\n            <jats:italic>\n              K\n              <jats:sub>m<\/jats:sub>\n            <\/jats:italic>\n            ), rates of free-radical formation from isoniazid oxidation, and, moreover, abilities to activate isoniazid. The A110V amino acid replacement did not result in significant alteration of KatG activities except that the peroxidase activity was enhanced. The other mutations, however, resulted in modestly reduced catalase and peroxidase catalytic efficiencies and, for the four mutants tested, significantly lower activities to oxidize isoniazid. Compared to the wild-type enzyme, the ability of the KatG\n            <jats:sup>L634F<\/jats:sup>\n            , KatG\n            <jats:sup>A139P<\/jats:sup>\n            , and KatG\n            <jats:sup>D735A<\/jats:sup>\n            variants to activate isoniazid decreased by 36%, 76%, and 73%, respectively, whereas the KatG\n            <jats:sup>S315N<\/jats:sup>\n            and KatG\n            <jats:sup>L619P<\/jats:sup>\n            variants completely lost their abilities to convert isoniazid into the InhA inhibitor. In addition, the inclusion of exogenous Mn\n            <jats:sup>2+<\/jats:sup>\n            to the isoniazid activation reaction mix significantly improved the ability of wild-type and KatG mutants to produce the InhA inhibitor.\n          <\/jats:p>","DOI":"10.1128\/aac.47.2.670-675.2003","type":"journal-article","created":{"date-parts":[[2003,1,23]],"date-time":"2003-01-23T21:05:59Z","timestamp":1043355959000},"page":"670-675","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":70,"title":["Isoniazid Activation Defects in Recombinant\n            <i>Mycobacterium tuberculosis<\/i>\n            Catalase-Peroxidase (KatG) Mutants Evident in InhA Inhibitor Production"],"prefix":"10.1128","volume":"47","author":[{"given":"Chih-Jen","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Biology and Biochemistry, University of Houston, Houston, Texas 77204-5001"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benfang","family":"Lei","sequence":"additional","affiliation":[{"name":"Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Musser","sequence":"additional","affiliation":[{"name":"Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiao-Chun","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Biology and Biochemistry, University of Houston, Houston, Texas 77204-5001"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8284673"},{"key":"e_1_3_2_3_2","first-page":"357","volume":"65","year":"1952","unstructured":"Bernstein, J., W. A. Lott, B. A. Steinberg, and H. L. Yale. 1952. Chemotherapy of experimental tuberculosis V. Isonicotinic acid hydrazide (Nydrazid) and related compounds. Am. Rev. Tuberc.65:357-364.","journal-title":"Am. Rev. Tuberc."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"9975","DOI":"10.1021\/bi0005815","volume":"39","year":"2000","unstructured":"Chouchane, S., I. Lippai, and R. S. Magliozzo. 2000. Catalase-peroxidase (Mycobacterium tuberculosis KatG) catalysis and isoniazid activation. Biochemistry39:9975-9983.","journal-title":"Biochemistry"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.16.1.104"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.116.3006.129"},{"key":"e_1_3_2_7_2","unstructured":"Fuhrhop J. H. and K. M. Smith . 1975. Laboratory methods p. 804-807. In K. M. Smith (ed.) Prophyrins and metalloporphyrins. Elsevier Scientific Publishing Co. New York N.Y."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.7.1601"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1995.tb02238.x"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91338-2"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.175.13.4255-4259.1993"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(75)90047-8"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1995.0065"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja00095a063"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.5.2834"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1021\/ja00122a038","volume":"117","year":"1995","unstructured":"Johnsson, K., D. S. King, and P. G. Schultz. 1995. The studies on the mechanism of action of isoniazid and ethionamide in the chemotherapy of tuberculosis. J. Am. Chem. Soc.117:5009-5010.","journal-title":"J. Am. Chem. Soc."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.4.2520"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1139\/o90-153"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"22290","DOI":"10.1074\/jbc.270.38.22290","volume":"270","year":"1995","unstructured":"Marcinkeviciene, J. A., R. S. Magliozzo, and J. S. Blanchard. 1995. Purification and characterization of the Mycobacterium smegmatis catalase-peroxidase involved in isoniazid activation. J. Biol. Chem.270:22290-22295.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.9.2187"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5369.1607"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03550100059039"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.4.954"},{"key":"e_1_3_2_25_2","first-page":"6","volume":"65","year":"1990","unstructured":"Murray, C. J. L., K. Styblo, and A. Rouillon. 1990. Tuberculosis in developing countries: burden, intervention and cost. Bull. Int. Union Tuberc. Lung Dis.65:6-24.","journal-title":"Bull. Int. Union Tuberc. Lung Dis."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.8.4.496"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/173.1.196"},{"key":"e_1_3_2_28_2","first-page":"761","volume":"65","year":"1952","unstructured":"Pansy, F., H. Stander, and R. Donovick. 1952. In vitro studies on isonicotinic acid hydrazide. Am. Rev. Tuber.65:761-764.","journal-title":"Am. Rev. Tuber."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1054\/tuld.1998.0002"},{"key":"e_1_3_2_30_2","first-page":"402","volume":"65","year":"1952","unstructured":"Robitzek, E. H., and I. J. Selikoff. 1952. Hydrazine derivatives of isonicotinic acid (Rimfon, Marsilid) in the treatment of active progressive caseous-pneumonic tuberculosis. Am. Rev. Tuberc.65:402-428.","journal-title":"Am. Rev. Tuberc."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1996.00133.x"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.279.5347.98"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3380753"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)36719-5"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.2.1.29"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1021\/bi00483a003","volume":"29","year":"1990","unstructured":"Wang, J., J. M. Mauro, S. L. Oatley, L. A. Fishel, V. A. Ashford, N. H. Xuong, and J. Kraut. 1990. X-ray structures of recombinant yeast cytochrome c peroxidase and three heme-cleft mutants prepared by site-directed mutagenesis. Biochemistry29:7160-7173.","journal-title":"Biochemistry"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0167-4838(91)90004-J","volume":"1080","year":"1991","unstructured":"Welinder, K. G. 1991. Bacterial catalase-peroxidases are gene duplicated members of the plant peroxidase superfamily. Biochim. Biophys. Acta1080:215-220.","journal-title":"Biochim. Biophys. Acta"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi982023k"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1086\/514096"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1099\/00221287-63-1-41","volume":"63","year":"1970","unstructured":"Winder, F. G., and P. B. Collins. 1970. Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis. J. Gen. Microbiol.63:41-48.","journal-title":"J. Gen. Microbiol."},{"key":"e_1_3_2_41_2","unstructured":"World Health Organization . 2000. Antituberculosis drug resistance in the world. Report no. 2: prevalence and trends 2. World Health Organization Geneva Switzerland."},{"key":"e_1_3_2_42_2","unstructured":"World Health Organization . 2001. Global tuberculosis control 2001. World Health Organization Geneva Switzerland."},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1110\/ps.ps.09902","volume":"11","year":"2002","unstructured":"Yu, S., S. Chouchane, and M. R. S. 2002. Characterization of the W321F mutant of Mycobacterium tuberculosis catalase-peroxidase KatG. Protein Sci.11:58-64.","journal-title":"Protein Sci."},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1021\/ja9639731","volume":"119","year":"1997","unstructured":"Zabinski, R. F., and J. S. Blanchard. 1997. The requirement for manganese and oxygen in the isoniazid-dependent inactivation of Mycobacterium tuberculosis enoyl reductase. J. Am. Chem. Soc.119:2331-2332.","journal-title":"J. Am. Chem. Soc."},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/358591a0"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.2.670-675.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.2.670-675.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T17:56:40Z","timestamp":1645466200000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.47.2.670-675.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["10.1128\/AAC.47.2.670-675.2003"],"URL":"https:\/\/doi.org\/10.1128\/aac.47.2.670-675.2003","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]},"assertion":[{"value":"2002-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-11-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}